Home >

Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

LOGIN TO START A DISCUSSION
Molecular Oncology Tumor Board
ASCO University
Nov 09, 2016 11:09 AM
Read more to answer the following questions:

 Recognize the clinical characteristics and outcomes for patients with FLT3 mutations?
Describe the role of FLT3 inhibitors for the initial treatment of AML?
Understand the role of gene mutations, including CLT3,  in the pathologic classification of...
International
ASCO International Affairs
Oct 25, 2016 3:08 PM
The American Society of Clinical Oncology, in collaboration with the Ghana Medical Association, presented a two-day Cancer Control in Primary Care course focused on breast and cervical cancers in Accra, Ghana in September 2016. In addition to lectures, the course included breakout sessions with...
Molecular Oncology Tumor Board
ASCO University
Oct 12, 2016 9:33 AM
Read more to answer the following questions: Who should get routine molecular testing at diagnosis for NSCLC and what tests should be performed? What is the most appropriate initial treatment for this patient?
Research and Meeting News
Virginia D. Anderson
Oct 06, 2016 6:34 PM
The Yale School of Public Health TREC Training Workshop is geared to early-career basic, clinical, and population scientists who are interested in energy balance and cancer research from a transdisciplinary and translational perspective. Seminars...
Research and Meeting News
Christina Koury
Oct 03, 2016 7:03 PM
Applications for The Pershing Square Sohn Cancer Research Alliance (PSSCRA) Prize for Young Investigators in Cancer Research are officially open. The prize of $200,000 per year for up to 3 years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue...

Pages